Sunday, December 03, 2006
Pfizer ends trials development on cholesterol drug - MarketWatch
¶ 4:45 PM 
 The Money Times | Pfizer ends trials development on cholesterol drug MarketWatch - By Robert Daniel MarketWatch. TEL AVIV (MarketWatch) -- Pfizer Inc. said it halted all clinical trials and development of torcetrapib which was part of the company's efforts to help boost good cholesterol. Pfizer shares at risk following heart-drug failure Pfizer hit by failure of cholesterol drug |
RSS :
